AirBoss Manufactured Products’ (“AMP”) defense business awarded a contract from the U.S. Government valued at up to $82.3M for ADG Molded Lightweight Overboots (“MALOs”); AirBoss Rubber Solutions ...
AirBoss of America Corp. (TSX: BOS) (OTCQX: ABSSF) (the "Company" or "AirBoss") today announced its unaudited fourth quarter and annual 2024 results.
5d
Tech Xplore on MSN'One-pot' technique creates inorganic and polymer battery electrolytes simultaneouslyCreating battery electrolytes—the component that carries the charged particles back and forth between a battery's two ...
4h
Astronomy on MSNStrange microbes on Earth might help us understand life on VenusIf venusian clouds contain life, it will be very different than what we know. But terrestrial analogs might still give us ...
From artificial colors linked to hyperactivity to preservatives associated with cancer risk, these common food additives could be secretly impacting your health ...
Scientists have discovered 'berkelocene,' the first organometallic molecule to be characterized containing the heavy element berkelium. The breakthrough disrupts long-held theories about the chemistry ...
Inorganic chemistry is the study of the structure, properties and reactions of all chemical elements and compounds except for organic compounds (hydrocarbons and their derivatives). While water ...
The agency has ordered compounding pharmacies to stop making compound versions of GLP-1 drugs now that the drugs are no longer in short supply. Eli Lilly, the maker of Zepbound and Mounjaro, and Novo ...
BLK wraps up the acquisition of Preqin. Will Preqin and other strategic buyouts help drive the company's financials going ...
A quality compounder is a business that not only sports durable competitive advantages but also builds on its success by consistently reinvesting its profits at high returns. Companies such as ...
The company has a proven model combining organic and inorganic growth. This compounder could grow for years, if not decades. There are many methods investors can employ, including value investing ...
APhA, in a formal comment letter, reiterated its concerns with FDA's list of drugs that present ... identified as "demonstrably difficult to compound" without becoming a manufacturer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results